Insight Molecular Diagnostics (IMDX) P/B (2016 - 2026)
Insight Molecular Diagnostics (IMDX) P/B from Jan 4, 2016 to Jul 20, 2026. The TTM Insight Molecular Diagnostics (IMDX) P/B is -14.62. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Insight Molecular Diagnostics (IMDX)
| Year | P/B | Change |
|---|---|---|
| 2026 | -14.62 | +113.78% |
| 2025 | -6.84 | +101.99% |
| 2024 | -3.39 | -692.42% |
| 2023 | 0.57 | +15.38% |
| 2022 | 0.50 | -83.86% |
| 2021 | 3.07 | -37.80% |
| 2020 | 4.93 | +18.58% |
| 2019 | 4.16 | -74.64% |
| 2018 | 16.41 | -9.58% |
| 2017 | 18.15 | +13.82% |
| 2016 | 15.94 | N/A |
Comparison Insight Molecular Diagnostics (IMDX) P/B with competitors
Insight Molecular Diagnostics (IMDX) P/B is -14.62.